|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Fan L, Strasser-weippl K, Li JJ, St Louis
J, Finkelstein DM, Yu KD, Chen WQ, Shao ZM and Goss PE: Breast
cancer in China. Lancet Oncol. 15:e279–e289. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Elfar GA, Ebrahim MA, Elsherbiny NM and
Eissa LA: Validity of osteoprotegerin and receptor activator of
NF-κB ligand for the detection of bone metastasis in breast cancer.
Oncol Res. 25:641–650. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Uehara M, Kinoshita T, Hojo T,
Akashi-Tanaka S, Iwamoto E and Fukutomi T: Long-term prognostic
study of carcinoembryonic antigen (CEA) and carbohydrate antigen
15-3 (CA 15-3) in breast cancer. Int J Clin Oncol. 13:447–451.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Duffy MJ, Evoy D and McDermott EW: CA
15-3: Uses and limitation as a biomarker for breast cancer. Clin
Chim Acta. 411:1869–1874. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
O'Donoghue C, Eklund M, Ozanne EM and
Esserman LJ: Aggregate cost of mammography screening in the United
States: Comparison of current practice and advocated guidelines.
Ann Intern Med. 160:1452014. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Vogelstein B, Papadopoulos N, Velculescu
VE, Zhou S, Diaz LA Jr and Kinzler KW: Cancer genome landscapes.
Science. 339:1546–1558. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Luo J and Ellis MJ: Microarray data
analysis in neoadjuvant biomarker studies in estrogen
receptor-positive breast cancer. Breast Cancer Res. 12:1122010.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chen C, Li Z, Yang Y, Xiang T, Song W and
Liu S: Microarray expression profiling of dysregulated long
non-coding RNAs in triple-negative breast cancer. Cancer Biol Ther.
16:856–865. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Makoukji J, Makhoul NJ, Khalil M, El-Sitt
S, Aldin ES, Jabbour M, Boulos F, Gadaleta E, Sangaralingam A,
Chelala C, et al: Gene expression profiling of breast cancer in
Lebanese women. Sci Rep. 6:366392016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Cizkova M, Cizeron-Clairac G, Vacher S,
Susini A, Andrieu C, Lidereau R and Bièche I: Gene expression
profiling reveals new aspects of PIK3CA mutation in
ERalpha-positive breast cancer: Major implication of the Wnt
signaling pathway. PLoS One. 5:e156472010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Richardson AL, Wang ZC, De Nicolo A, Lu X,
Brown M, Miron A, Liao X, Iglehart JD, Livingston DM and Ganesan S:
X chromosomal abnormalities in basal-like human breast cancer.
Cancer Cell. 9:121–132. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Turashvili G, Bouchal J, Baumforth K, Wei
W, Dziechciarkova M, Ehrmann J, Klein J, Fridman E, Skarda J,
Srovnal J, et al: Novel markers for differentiation of lobular and
ductal invasive breast carcinomas by laser microdissection and
microarray analysis. BMC Cancer. 7:552007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kretschmer C, Sterner-Kock A, Siedentopf
F, Schoenegg W, Schlag PM and Kemmner W: Identification of early
molecular markers for breast cancer. Mol Cancer. 10:152011.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Planche A, Bacac M, Provero P, Fusco C,
Delorenzi M, Stehle JC and Stamenkovic I: Identification of
prognostic molecular features in the reactive stroma of human
breast and prostate cancer. PLoS One. 6:e186402011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Irizarry RA, Hobbs B, Collin F,
Beazer-Barclay YD, Antonellis KJ, Scherf U and Speed TP:
Exploration, normalization, and summaries of high density
oligonucleotide array probe level data. Biostatistics. 4:249–264.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Gautier L, Cope L, Bolstad BM and Irizarry
RA: affy-analysis of Affymetrix GeneChip data at the probe level.
Bioinformatics. 20:307–315. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chen C, Grennan K, Badner J, Zhang D,
Gershon E, Jin L and Liu C: Removing batch effects in analysis of
expression microarray data: An evaluation of six batch adjustment
methods. PLoS One. 6:e172382011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ritchie ME, Phipson B, Wu D, Hu Y, Law CW,
Shi W and Smyth GK: limma powers differential expression analyses
for RNA-sequencing and microarray studies. Nucleic Acids Res.
43:e472015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Jiao X, Sherman BT, da Huang W, Stephens
R, Baseler MW, Lane HC and Lempicki RA: DAVID-WS: A stateful web
service to facilitate gene/protein list analysis. Bioinformatics.
28:1805–1806. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Gene Ontology Consortium: The Gene
Ontology (GO) project in 2006. Nucleic Acids Res. 34:(Database
Issue). D322–D326. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ogata H, Goto S, Sato K, Fujibuchi W, Bono
H and Kanehisa M: KEGG: Kyoto encyclopedia of genes and genomes.
Nucleic Acids Res. 27:29–34. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Szklarczyk D, Franceschini A, Kuhn M,
Simonovic M, Roth A, Minguez P, Doerks T, Stark M, Muller J, Bork
P, et al: The STRING database in 2011: Functional interaction
networks of proteins, globally integrated and scored. Nucleic Acids
Res. 39:(Database Issue). D561–D568. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Smoot ME, Ono K, Ruscheinski J, Wang PL
and Ideker T: Cytoscape 2.8: New features for data integration and
network visualization. Bioinformatics. 27:431–432. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Bader GD and Hogue CW: An automated method
for finding molecular complexes in large protein interaction
networks. BMC Bioinformatics. 4:22003. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Gray JM, Rasanayagam S, Engel C and Rizzo
J: State of the evidence 2017: An update on the connection between
breast cancer and the environment. Environ Health. 16:942017.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Hamdi Y, Soucy P, Adoue V, Michailidou K,
Canisius S, Lemaçon A, Droit A, Andrulis IL, Anton-Culver H, Arndt
V, et al: Association of breast cancer risk with genetic variants
showing differential allelic expression: Identification of a novel
breast cancer susceptibility locus at 4q21. Oncotarget.
7:80140–80163. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zheng T, Wang A, Hu D and Wang Y:
Molecular mechanisms of breast cancer metastasis by gene expression
profile analysis. Mol Med Rep. 16:4671–4677. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ikeda K, Horie-Inoue K and Inoue S:
Identification of estrogen-responsive genes based on the DNA
binding properties of estrogen receptors using high-throughput
sequencing technology. Acta Pharmacol Sin. 36:24–31. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Pounds S and Morris SW: Estimating the
occurrence of false positives and false negatives in microarray
studies by approximating and partitioning the empirical
distribution of P-values. Bioinformatics. 19:1236–1242. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kupfer P, Guthke R, Pohlers D, Huber R,
Koczan D and Kinne RW: Batch correction of microarray data
substantially improves the identification of genes differentially
expressed in rheumatoid arthritis and osteoarthritis. BMC Med
Genomics. 5:232012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Liang B, Li C and Zhao J: Identification
of key pathways and genes in colorectal cancer using bioinformatics
analysis. Med Oncol. 33:1112016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Lyons TR, O'Brien J, Borges VF, Conklin
MW, Keely PJ, Eliceiri KW, Marusyk A, Tan AC and Schedin P:
Postpartum mammary gland involution drives progression of ductal
carcinoma in situ through collagen and COX-2. Nat Med.
17:1109–1115. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
34
|
Provenzano PP, Inman DR, Eliceiri KW,
Knittel JG, Yan L, Rueden CT, White JG and Keely PJ: Collagen
density promotes mammary tumor initiation and progression. BMC Med.
6:112008. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Cox TR, Bird D, Baker AM, Barker HE, Ho
MW, Lang G and Erler JT: LOX-mediated collagen crosslinking is
responsible for fibrosis-enhanced metastasis. Cancer Res.
73:1721–1732. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Chia J, Kusuma N, Anderson R, Parker B,
Bidwell B, Zamurs L, Nice E and Pouliot N: Evidence for a role of
tumor-derived laminin-511 in the metastatic progression of breast
cancer. Am J Pathol. 170:2135–2148. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Chang HY, Nuyten DS, Sneddon JB, Hastie T,
Tibshirani R, Sørlie T, Dai H, He YD, van't Veer LJ, Bartelink H,
et al: Robustness, scalability, and integration of a wound-response
gene expression signature in predicting breast cancer survival.
Proc Natl Acad Sci USA. 102:3738–3743. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Finak G, Bertos N, Pepin F, Sadekova S,
Souleimanova M, Zhao H, Chen H, Omeroglu G, Meterissian S, Omeroglu
A, et al: Stromal gene expression predicts clinical outcome in
breast cancer. Nat Med. 14:518–527. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Peters JM, Shah YM and Gonzalez FJ: The
role of peroxisome proliferator-activated receptors in
carcinogenesis and chemoprevention. Nat Rev Cancer. 12:181–195.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Boitier E, Gautier JC and Roberts R:
Advances in understanding the regulation of apoptosis and mitosis
by peroxisome-proliferator activated receptors in pre-clinical
models: Relevance for human health and disease. Comp Hepatol.
2:32003. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Robbins GT and Nie D: PPAR gamma,
bioactive lipids, and cancer progression. Front Biosci (Landmark
Ed). 17:1816–1834. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
42
|
Liu H, Zang C, Fenner MH, Possinger K and
Elstner E: PPARgamma ligands and ATRA inhibit the invasion of human
breast cancer cells in vitro. Breast Cancer Res Treat. 79:63–74.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Apostoli AJ, Skelhorne-Gross GE, Rubino
RE, Peterson NT, Di Lena MA, Schneider MM, SenGupta SK and Nicol
CJ: Loss of PPARγ expression in mammary secretory epithelial cells
creates a pro-breast tumorigenic environment. Int J Cancer.
134:1055–1066. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Lan J, Huang HY, Lee SW, Chen TJ, Tai HC,
Hsu HP, Chang KY and Li CF: TOP2A overexpression as a poor
prognostic factor in patients with nasopharyngeal carcinoma. Tumour
Biol. 35:179–187. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Milde-Langosch K, Karn T, Müller V, Witzel
I, Rody A, Schmidt M and Wirtz RM: Validity of the proliferation
markers Ki67, TOP2A, and RacGAP1 in molecular subgroups of breast
cancer. Breast Cancer Res Treat. 137:57–67. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Şahin S, Işık Gönül İ, Çakır A, Seçkin S
and Uluoğlu Ö: Clinicopathological significance of the
proliferation markers Ki67, RacGAP1, and Topoisomerase 2 alpha in
breast cancer. Int J Surg Pathol. 24:607–613. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Ambrosini G, Adida C and Altieri DC: A
novel anti-apoptosis gene, survivin, expressed in cancer and
lymphoma. Nat Med. 3:917–921. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Tanaka K, Iwamoto S, Gon G, Nohara T,
Iwamoto M and Tanigawa N: Expression of survivin and its
relationship to loss of apoptosis in breast carcinomas. Clin cancer
Res. 6:127–134. 2000.PubMed/NCBI
|
|
49
|
Kappler M, Kotzsch M, Bartel F, Füssel S,
Lautenschläger C, Schmidt U, Würl P, Bache M, Schmidt H, Taubert H
and Meye A: Elevated expression level of survivin protein in
soft-tissue sarcomas is a strong independent predictor of survival.
Clin Cancer Res. 9:1098–1104. 2003.PubMed/NCBI
|
|
50
|
Ghaffari K, Hashemi M, Ebrahimi E and
Shirkoohi R: BIRC5 genomic copy number variation in early-onset
breast cancer. Iran Biomed J. 20:241–245. 2016.PubMed/NCBI
|
|
51
|
Santamaría D, Barrière C, Cerqueira A,
Hunt S, Tardy C, Newton K, Cáceres JF, Dubus P, Malumbres M and
Barbacid M: Cdk1 is sufficient to drive the mammalian cell cycle.
Nature. 448:811–815. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Kourea HP, Koutras AK, Scopa CD, Marangos
MN, Tzoracoeleftherakis E, Koukouras D and Kalofonos HP: Expression
of the cell cycle regulatory proteins p34cdc2, p21waf1, and p53 in
node negative invasive ductal breast carcinoma. Mol Pathol.
56:328–335. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Galindo-Moreno M, Giráldez S, Sáez C,
Japón MÁ, Tortolero M and Romero F: Both p62/SQSTM1-HDAC6-dependent
autophagy and the aggresome pathway mediate CDK1 degradation in
human breast cancer. Sci Rep. 7:100782017. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Miyazaki T and Arai S: Two distinct
controls of mitotic cdk1/cyclin B1 activity requisite for cell
growth prior to cell division. Cell Cycle. 6:1419–1425. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Pines J and Hunter T: Human cyclin A is
adenovirus E1A-associated protein p60 and behaves differently from
cyclin B. Nature. 346:760–763. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Uhlen M, Oksvold P, Fagerberg L, Lundberg
E, Jonasson K, Forsberg M, Zwahlen M, Kampf C, Wester K, Hober S,
et al: Towards a knowledge-based Human Protein Atlas. Nat
Biotechnol. 28:1248–1250. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Ding K, Li W, Zou Z, Zou X and Wang C:
CCNB1 is a prognostic biomarker for ER+ breast cancer. Med
Hypotheses. 83:359–364. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Durfee T, Becherer K, Chen PL, Yeh SH,
Yang Y, Kilburn AE, Lee WH and Elledge SJ: The retinoblastoma
protein associates with the protein phosphatase type 1 catalytic
subunit. Genes Dev. 7:555–569. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Ciferri C, Pasqualato S, Screpanti E,
Varetti G, Santaguida S, Dos RG, Maiolica A, Polka J, De Luca JG,
De WP, et al: Implications for kinetochore-microtubule attachment
from the structure of an engineered Ndc80 complex. Cell.
133:427–439. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Diaz-Rodríguez E, Sotillo R, Schvartzman
JM and Benezra R: Hec1 overexpression hyperactivates the mitotic
checkpoint and induces tumor formation in vivo. Proc Natl Acad Sci
USA. 105:16719–16724. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
van't Veer LJ, Dai H, van de Vijver MJ, He
YD, Hart AA, Mao M, Peterse HL, van der Kooy K, Marton MJ,
Witteveen AT, et al: Gene expression profiling predicts clinical
outcome of breast cancer. Nature. 415:530–536. 2002. View Article : Google Scholar : PubMed/NCBI
|
